Approximately 50 million people across North America annually report some type of sleep problem including snoring and the symptoms of Obstructive Sleep Apnea (OSA). Now, with the Klearway™ appliance, available exclusively in Canada from Space Maintainers Laboratories Canada Ltd., you can offer the clinically proven solution. To date, more than 10,000 patients worldwide have already benefited from the use of a Klearway™ appliance. Developed by Alan Lowe, DMD, PhD, FRCD(c), FACD, Professor and Chair of the Division of Orthodontics at the University of British Columbia’s Faculty of Dentistry, Klearway™ is the most thoroughly field tested and researched oral appliance for the treatment of snoring and OSA available. Because of the obvious life-threatening implications of sleep disorders, it is imperative that treatment commence only after the potential presence of other associated medical conditions, including sleep apnea, are ascertained. Prior to treatment with an oral appliance, the patient should be assessed by an attending physician and/or sleep specialist.

Utilizing a laser-welded (not soldered) advancement screw for superior longevity, Klearway™ facilitates slow and gradual forward movement of the mandible. A total of 44 positions available in increments of 0.25 mm (covering a full 11 mm range) permits the patient to adjust appliance according to his or her own comfort level under the guidance of the attending dentist.

Once warmed under hot water for easy insertion, the Klearway™’s thermoactive acrylic resin contracts as it cools, providing superior retention and fit. This significantly decreases soft tissue and tooth discomfort. Full occlusal coverage of both arches is provided, without encroaching on tongue space. Lateral and vertical jaw movements are permitted, allowing patients to yawn, swallow and drink water without dislodging the appliance.

Progressive titration capabilities together with excellent compliance give Klearway™ the highest reported treatment success of any oral appliance used for the treatment of snoring and OSA:

• Successfully treats 80% of mild to moderate OSA patients.
• Successfully treats 61% of severe OSA patients.
• Increases airway size in OSA patients particularly at the level of the velopharynx.
• Covert compliance monitoring shows that Klearway™ is worn on average 6.8 hours per night.
• Can be used to reduce vertical jaw posture which is significantly higher in OSA patients.